Prospeo
Hero Section BackgroundHero Section Background
Ephla Bio

Ephla Bio Revenue

Biotechnology Research1-10 Employees

$

Ephla Bio revenue & valuation

Annual revenue$513,330
Revenue per employee$86,000
Estimated valuation?$1,700,000
Total fundingNo funding

Key Contact at Ephla Bio

Flag of US

Robert Bao

Senior Director

Company overview

HeadquartersXX
Website
NAICS541714
Employees1-10

Ephla Bio Email Formats

Ephla Bio uses 1 email format. The most common is {first name} (e.g., john@ephlabio.com), used 100% of the time.

FormatExamplePercentage
{first name}
john@ephlabio.com
100%

About Ephla Bio

Ephla Bio is pioneering a novel approach for targeted therapies in B-cell pathologies with machine learning. Our team consists of clinicians and researchers from Stanford and the Francis Crick Institute, along with ex-Google engineers. We’re starting with a focus on autoimmune disorders, but will then expand to B-cell lymphomas, multiple myeloma, and other blood-based cancers.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry
Director

Employees by Department

Ephla Bio has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Ephla Bio has never raised funding before.

Frequently asked questions

Ephla Bio is located in XX.
Ephla Bio generates an estimated annual revenue of $513,330. This revenue figure reflects the company's market position and business performance in its industry.
Ephla Bio has an estimated valuation of $1,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Ephla Bio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles